These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8951889)

  • 21. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
    Williams S; Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proteins of Alzheimer's disease].
    Piekiełko A
    Postepy Biochem; 1999; 45(2):116-22. PubMed ID: 10581635
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances fuel Alzheimer's conundrum.
    Mattson MP
    Nat Genet; 1997 Nov; 17(3):254-6. PubMed ID: 9354778
    [No Abstract]   [Full Text] [Related]  

  • 24. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):455-7. PubMed ID: 11523146
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and processing of pathologic proteins in Alzheimer's disease.
    Anderton BH
    Hippocampus; 1993; 3 Spec No():227-37. PubMed ID: 8287100
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurotoxicity of Alzheimer's beta-amyloid protein and membrane lipids].
    Kawahara M; Kuroda Y
    Tanpakushitsu Kakusan Koso; 1999 Oct; 44(13):1982-7. PubMed ID: 10517107
    [No Abstract]   [Full Text] [Related]  

  • 29. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What causes Abeta amyloidosis in the brain?].
    Matsubara E; Yanagisawa K
    No To Shinkei; 2005 Oct; 57(10):829-38. PubMed ID: 16277228
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dementia, Alzheimer's disease, Abeta peptide and tau protein].
    Duyckaerts C; He Y; Seilhean D; Hauw JJ
    Ann Pathol; 1995; 15(1):6-10. PubMed ID: 7702671
    [No Abstract]   [Full Text] [Related]  

  • 33. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tombstone in Alzheimer's?
    Mattson MP; Carney JW; Butterfield DA
    Nature; 1995 Feb; 373(6514):481. PubMed ID: 7845457
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alzheimer's disease and the proteins].
    Morishima-Kawashima M; Saido TC; Ihara Y
    Tanpakushitsu Kakusan Koso; 2001 Aug; 46(11 Suppl):1798-804. PubMed ID: 11579581
    [No Abstract]   [Full Text] [Related]  

  • 36. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of cholesterol in the pathogenesis of Alzheimer's disease].
    Michikawa M
    Nihon Ronen Igakkai Zasshi; 2001 Nov; 38(6):751-3. PubMed ID: 11774713
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic factors in Alzheimer's disease.
    Bird TD
    N Engl J Med; 2005 Mar; 352(9):862-4. PubMed ID: 15745976
    [No Abstract]   [Full Text] [Related]  

  • 40. [Apolipoprotein E polymorphism in Alzheimer's disease].
    Shimohama S
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):173-7. PubMed ID: 8648892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.